Delivery Order SPE2DB25D3504-SPE2DB25FVVTC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,254.60 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 13, 2025, with completion targeted for August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,175.66 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (quantity: 8 units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a $3,354.92 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a pharmaceutical supply delivery to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $35,526.80 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity: 8 units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,971.64 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity 8). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 21, 2025, and represents a continuation of the contractor's pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $18,687.52 for NURTEC ODT 75 mg tablets (8 count) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed-price, non-set-aside contract with performance at the vendor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of the agency's pharmaceutical procurement operations and falls under AmerisourceBergen's broader relationship...
- The Defense Logistics Agency awarded a $7,797.87 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The contract is scheduled for completion by July 23, 2025, reflecting the expedited nature of this pharmaceutical procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,515.86 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical supply to support federal medical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $8,450.73 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count package) on July 29, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded without set-aside designation, with performance taking...
- The Defense Logistics Agency awarded a $5,307.30 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's facility in...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVVTCDelivery Order
The Defense Logistics Agency awarded a $4,771.95 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on July 29, 2025, with completion scheduled for July 30, 2025. This non-competitive delivery order represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The DLA Troop Support is simultaneously developing next-generation Pharmaceutical Prime Vendor Global Program contracts anticipated to involve multiple regional awards, underscoring the strategic importance of reliable pharmaceutical distribution partnerships within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 7/29/25 |